Bschor T - Search Results

1

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

Bschor T, Berghöfer A, Ströhle A, Kunz D, Adli M, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. J Clin Psychopharmacol. 2002 Aug;22(4):427-30. doi: 10.1097/00004714-200208000-00016. J Clin Psychopharmacol. 2002. PMID: 12172345 Clinical Trial.

2

[Thyroid gland function in lithium treatment].

Bschor T, Bauer M. Bschor T, et al. Nervenarzt. 1998 Mar;69(3):189-95. doi: 10.1007/s001150050259. Nervenarzt. 1998. PMID: 9565972 Review. German.

3

[Lithium in the treatment of acute depression].

Adli M, Bschor T, Canata B, Döpfmer S, Bauer M. Adli M, et al. Among authors: bschor t. Fortschr Neurol Psychiatr. 1998 Oct;66(10):435-41. doi: 10.1055/s-2007-995282. Fortschr Neurol Psychiatr. 1998. PMID: 9825248 Review. German.

4

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.

Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen B. Bauer M, et al. Among authors: bschor t. Am J Psychiatry. 2000 Sep;157(9):1429-35. doi: 10.1176/appi.ajp.157.9.1429. Am J Psychiatry. 2000. PMID: 10964859 Clinical Trial.

5

Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study.

Bschor T, Müller-Oerlinghausen B, Ulrich G. Bschor T, et al. Clin Electroencephalogr. 2001 Jan;32(1):36-9. doi: 10.1177/155005940103200110. Clin Electroencephalogr. 2001. PMID: 11202141

6

Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders.

Bauer M, Priebe S, Berghöfer A, Bschor T, Kiesslinger U, Whybrow PC. Bauer M, et al. Among authors: bschor t. J Affect Disord. 2001 Apr;64(1):35-42. doi: 10.1016/s0165-0327(00)00215-9. J Affect Disord. 2001. PMID: 11292518 Clinical Trial.

7

Predictors of response to lithium augmentation in tricyclic antidepressant-resistant depression.

Bschor T, Canata B, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. J Affect Disord. 2001 May;64(2-3):261-5. doi: 10.1016/s0165-0327(00)00211-1. J Affect Disord. 2001. PMID: 11313093

8

Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression.

Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, Modell S, Künzel H, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. Neuropsychopharmacology. 2002 Sep;27(3):470-8. doi: 10.1016/S0893-133X(02)00323-8. Neuropsychopharmacology. 2002. PMID: 12225704 Clinical Trial.

9

Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders.

Bauer M, Berghöfer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R, Adli M, Baethge C, Müller-Oerlinghausen B. Bauer M, et al. Among authors: bschor t. Neuropsychopharmacology. 2002 Oct;27(4):620-8. doi: 10.1016/S0893-133X(02)00320-2. Neuropsychopharmacology. 2002. PMID: 12377398 Clinical Trial.

10

Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.

Bschor T, Baethge C, Adli M, Eichmann U, Ising M, Uhr M, Müller-Oerlinghausen B, Bauer M. Bschor T, et al. Depress Anxiety. 2003;17(1):43-8. doi: 10.1002/da.10078. Depress Anxiety. 2003. PMID: 12577277 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters